Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages

Clinical and Experimental Immunology

Volumn 134, Issue 1, 2003, Pages 57-62

  Benson, R M ^a   Minter, L M ^b   Osborne, B A ^b   Granowitz, Eric V ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Cytokine; Hyperbaric oxygenation; Interleukin 1; Monocyte; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; LIPID A; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHYTOHEMAGGLUTININ; PHYTOHEMAGGLUTININ A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; HYPEROXIA; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; RNA TRANSLATION; STEADY STATE; TEMPERATURE SENSITIVITY;

CELLS, CULTURED; CYTOKINES; HUMANS; HYPERBARIC OXYGENATION; IMMUNOSUPPRESSION; INTERLEUKIN-1; LIPID A; LIPOPOLYSACCHARIDES; MACROPHAGES; PHYTOHEMAGGLUTININS; RNA, MESSENGER; STIMULATION, CHEMICAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141650597     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02248.x     Document Type: Article

References (35)

1. Horai R, Saijo S, Tanioka H et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000; 191:313-20.
2. Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10:4025-31.
3. Bresnihan B, Alvaro-Gracia JM, Cobby M et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998; 41:2196-204.
4. Elliott MK, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344:1105-10.
5. Camporesi EM ed. Hyperbaric oxygen therapy: a committee report. Kensington, MD: Undersea and Hyperbaric Medical Society, 1996.
6. Brenner I, Shepard RJ, Shek PN. Immune function in hyperbaric environments, diving, and decompression. Undersea Hyper Med 1999; 26:27-39.
7. Murphy SA, Hyams JS, Fisher AB, Root RK. Effects of oxygen exposure on in vitro function of pulmonary alveolar macrophages. J Clin Invest 1975; 56:503-11.
8. van den Blink B, van der Kleij AJ, Versteeg HH, Peppelenbosch MP. Immunomodulatory effect of oxygen and pressure. Comp Biochem Physiol Physiol 2002; 132:193-7.
9. Inamoto Y, Okuno F, Saito K et al. Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Comm 1991; 179:886-91.
10. Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-α) secretion from rat macrophages. Clin Exp Immunol 1995; 102:655-9.
11. Weisz G, Lavy A, Adir Y et al. Modification of in vivo and in vitro TNF-α, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol 1997; 17:154-9.
12. Endres S, Cannon JG, Ghorbani R et al. In vitro production of IL 1β, IL 1α, TNF and IL 2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989; 19:2327-33.
13. Endres S, Ghorbani R, Lonnemann G, van der Meer JWM, Dinarello CA. Measurement of immunoreactive interleukin-1β from human mononuclear cells optimization of recovery, intrasubject consistency, and comparison with interleukin-1α and tumor necrosis factor. Clin Immunol Immunopath 1988; 49:424-38.
14. White BA, Bancroft FC. Cytoplasmic dot hybridization. J Biol Chem 1982; 257:8569-72.
15. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987.
16. Granowitz EV, Skulsky EJ, Benson RM et al. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-γ secretion in whole blood cultures of healthy humans. Undersea Hyper Med 2002; 29:216-25.
17. Takano KJ, Takano T, Yamanouchi Y, Satou T. Pressure-induced apoptosis in human lymphocytes. Exp Cell Res 1997; 235:155-60.
18. Ganguly BJ, Tonomura N, Benson RM, Osborne BA, Granowitz EV. Hyperbaric oxygen enhances apoptosis in hematopoietic cells. Apoptosis 2002; 7:499-510.
19. Jensen JC, Pogrebniak HW, Pass HI, Buresh C, Merino MJ, Kauffman D. Role of tumor necrosis factor in oxygen toxicity. J Appl Physiol 1992; 72:1902-7.
20. 2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res 1995; 21:589-97.
21. Barazzone C, Tacchini-Cottier F, Vesin C, Rochat AF, Piguct P. Hyperoxia induces platelet activation and lung sequestration, an event dependent on tumor necrosis factor-α and CD11a. Am J Respir Cell Mol Biol 1996; 15:107-14.
22. Johnston CJ, Wright TW, Reed CK, Finkelstein JN. Comparison of adult and newborn pulmonary cytokine mRNA expression after hyperoxia. Exp Lung Res 1997; 23:537-52.
23. Piedboeuf B, Horowitz S, Johnston CJ et al. Interleukin-1 expression during hyperoxic lung injury in the mouse. Free Radic Biol Med 1998; 24:1446-54.
24. McIntyre KM, Dixon PS, Krock LP, Piepmeier EH Jr. The influence of hyperbaric oxygenation on leukocyte viability and surface protein expression. Aviat Space Environ Med 1997; 68:1129-33.
25. Tompach PC, Lew D, Stoll JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surg 1997; 26:82-6.
26. Kalns J, Krock L, Piepmeier E Jr. The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Res 1998; 18:363-8.
27. Luongo C, Imperatore F, Cuzzocrea S et al. Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med 1998; 26:1972-6.
28. Yamashita M, Yamashita M. Hyperbaric oxygen treatment attenuates cytokine induction after massive hemorrhage. Am J Physiol Endocrinol Metab 2000; 278:E811-6.
29. 2 reduces intestinal ischemia-reperfusion-induced TNF-α production and lung neutrophil sequestration. Eur J Appl Physiol 2001; 85:96-103.
30. Bitterman N, Bitterman H, Kinarty A, Melamed Y, Lahat N. Effect of single exposure to hyperbaric oxygen on blood mononuclear cells in human subjects. Undersea Hyper Med 1993; 20:197-204.
31. Bitterman N, Lahat N, Rosenwald T, Kinarty A, Melamed Y, Bitterman H. Effect of hyperbaric oxygen on tissue distribution of mononuclear cell subsets in the rat. J Appl Physiol 1994; 77:2355-9.
32. Yin W, Badr AE, Mychaski G, Zhang JH. Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res 2002; 926:165-71.
33. Xie Y, Cahill CM, Asea A, Auron PE, Calderwood SK. Heat shock proteins and regulation of cytokine expression. Infect Dis Obstet Gynecol 1999; 7:26-30.
34. Fuhlbrigge RC, Chaplin DD, Kiely J, Unanue ER. Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide. J Immunol 1987; 138:3799-802.
35. Haskill S, Johnson C, Eierman D, Becker S, Warren K. Adherence induces selective mRNA expression of monocyte mediators and protooncogenes. J Immunol 1988; 140:1690-4.